GK

Gerhard Koenig

Chief Executive Officer

Augustine Therapeutics

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Augustine Therapeutics
Industry
research
Employees
24.0
Seniority
C suite
Annual Revenue
1600000.0
Total Funding
107976705.0
Latest Funding
Series A

Technologies

Outlook Amazon AWS Google Tag Manager reCAPTCHA Mobile Friendly Nginx Google Maps Google Maps (Non Paid Users)

Keywords

biotechnology research hdac6 inhibitors neuromuscular disorders charcot-marie-tooth cmt neurodegenerative diseases machine learning neural networks axonal degeneration small molecule therapeutics chemotherapy-induced peripheral neuropathy cipn patient care clinical trials biotechnology drug development axon regeneration axonal transport therapeutic innovation regenerative medicine pharmacology biotech company preclinical research biomedical engineering genetic disorders personalized medicine metabolic diseases autoimmune diseases cns therapies orally bioavailable selective inhibitors disease-modifying therapies paresthesia pain relief clinical development new therapies drug discovery therapeutic applications medical research biotech funding scientific research clinical efficacy drug candidates biopharmaceuticals innovative treatments patient outcomes neuroprotective agents gene therapy therapeutic pipelines scientific partnerships artificial intelligence information technology & services health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans